25
TP53 mutations in circulating tumor DNA for response monitoring in patients with high grade serous carcinoma of ovary
TP53 mutations in circulating tumor DNA for response monitoring in patients with high grade serous carcinoma of ovary
Sunday, March 29, 2015: 2:29 PM
International Ballroom (Hilton Chicago)